Cysteine Proteases in MHC Class II Antigen Presentation
Cysteine Proteases in MHC Class II Antigen Presentation
批准号:
6580160
负责人:
Harold A Chapman
金额:
$33.96万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-01-01 至 2007-12-31
关键词:
MHC class II antigen T lymphocyte active sites antigen presentation asthma autoimmunity cellular immunity cellular polarity clinical research cysteine endopeptidases dendritic cells enzyme activity flow cytometry gene targeting genetically modified animals human subject immunoglobulin E immunoregulation laboratory mouse lung disorder mast cell molecular chaperones protease inhibitor site directed mutagenesis tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (provided by applicant): The endosomal cysteine protease, cathepsin S, has a key role in MHC class II (MHCII)-dependent immunity through its role in degradation of the MHCII-associated chaperone, the invariant chain (Ii). But studies of cathepsin S -/- mice also reveal unexpected findings. Cathepsin S deficiency predominantly affects Thl dependent immunity. IgE responses and Th2-driven pulmonary inflammation, while dependent on cysteine proteases, are normal or increased in cathepsin S -/- mice. Indeed baseline IgE levels and lung mRNA of proinflammatory cytokines in these mice are elevated. Surprisingly, high IgE levels and cytokines are mast cell-dependent. These observations imply additional proteases, and perhaps additional antigen presenting cells (APC), are important to MHCII function and that protease dysregulation can skew, not just block, MHCII-dependent immune responses. Experiments are directed toward understanding how proteases can effect polarization of T and B cell development relevant to lung disease. Mechanisms of peptide loading in cathepsin S-deficient APC will be defined. Mice deficient in the Ii-degrading APC protease cathepsin F have been recently generated and will be used to test the hypothesis that cathepsin F rescues MHC class II peptide display in myeloid APCs, thereby favoring Th2 polarization. Selective protease inhibitors will be used to determine if a set of protease activities in human APC are required for Th2 cytokine production by allergen stimulated T cells. The mechanisms by which mast cells promote APC-dependent IgE production will be explored by reconstitution of mast cell deficient mice (Wsh) with mast cells cultured from S-/- or cytokine deficient mice. The overall goal of this application is to understand the molecular basis for protease dependent polarization of T cell and B cell immune responses and to learn how to exploit this process to ameliorate CD4+ T cell driven disorders such as autoimmunity and asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients
-
批准号:10702133
-
项目类别:
-
资助金额:$215.3万
-
财政年份:2022
-
负责人:Harold A Chapman
-
依托单位:
Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients
-
批准号:10418169
-
项目类别:
-
资助金额:$45.38万
-
财政年份:2022
-
负责人:Harold A Chapman
-
依托单位:
Program to promote lung regeneration and block fibrosis
-
批准号:9893639
-
项目类别:
-
资助金额:$96.55万
-
财政年份:2020
-
负责人:Harold A Chapman
-
依托单位:
Program to promote lung regeneration and block fibrosis
-
批准号:10570862
-
项目类别:
-
资助金额:$96.88万
-
财政年份:2020
-
负责人:Harold A Chapman
-
依托单位:
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
-
批准号:10181019
-
项目类别:
-
资助金额:$120.21万
-
财政年份:2016
-
负责人:Harold A Chapman
-
依托单位:
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
-
批准号:9355470
-
项目类别:
-
资助金额:$94.83万
-
财政年份:2016
-
负责人:Harold A Chapman
-
依托单位:
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
-
批准号:10418711
-
项目类别:
-
资助金额:$118.64万
-
财政年份:2016
-
负责人:Harold A Chapman
-
依托单位:
Epithelial Stem/Progenitor Cells in Repair of the Injured Lung
-
批准号:9109038
-
项目类别:
-
资助金额:$49.63万
-
财政年份:2015
-
负责人:Harold A Chapman
-
依托单位:
Identification, Isolation, and Reprogramming Alveolar Epithelial Progenitor Cells
-
批准号:7676645
-
项目类别:
-
资助金额:$3.86万
-
财政年份:2008
-
负责人:Harold A Chapman
-
依托单位:
Urokinase Receptor Integrin Interactions in Lung Cancer
-
批准号:7318124
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Harold A Chapman
-
依托单位:
Urokinase Receptor Integrin Interactions in Lung Cancer
-
批准号:8079454
-
项目类别:
-
资助金额:$28.47万
-
财政年份:2007
-
负责人:Harold A Chapman
-
依托单位:
Urokinase Receptor Integrin Interactions in Lung Cancer
-
批准号:7623494
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2007
-
负责人:Harold A Chapman
-
依托单位:
Urokinase Receptor Integrin Interactions in Lung Cancer
-
批准号:7458005
-
项目类别:
-
资助金额:$29.35万
-
财政年份:2007
-
负责人:Harold A Chapman
-
依托单位:
Urokinase Receptor Integrin Interactions in Lung Cancer
-
批准号:7816702
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2007
-
负责人:Harold A Chapman
-
依托单位:
Role of Elastolytic Cathepsins in Emphysema
-
批准号:7430307
-
项目类别:
-
资助金额:$42.81万
-
财政年份:2001
-
负责人:Harold A Chapman
-
依托单位:
Role of Elastolytic Cathepsins in Emphysema
-
批准号:7630481
-
项目类别:
-
资助金额:$44.89万
-
财政年份:2001
-
负责人:Harold A Chapman
-
依托单位:
Role of Elastolytic Cathepsins in Emphysema
-
批准号:6619355
-
项目类别:
-
资助金额:$31.67万
-
财政年份:2001
-
负责人:Harold A Chapman
-
依托单位:
Role of Elastolytic Cathepsins in Emphysema
-
批准号:6896391
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2001
-
负责人:Harold A Chapman
-
依托单位:
Role of Elastolytic Cathepsins in Emphysema
-
批准号:6752914
-
项目类别:
-
资助金额:$32.37万
-
财政年份:2001
-
负责人:Harold A Chapman
-
依托单位:
Role of Elastolytic Cathepsins in Emphysema
-
批准号:7009143
-
项目类别:
-
资助金额:$42.17万
-
财政年份:2001
-
负责人:Harold A Chapman
-
依托单位:
海外基金